MedTrace Logo

Improving Care for Patients With Chronic Kidney Disease Using EMRALD

NCT02274298 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2016-10-14

No results posted yet for this study

Summary

This pragmatic cluster randomized controlled trial will test the impact of feedback and a toolkit aimed at improving the management of chronic kidney disease (CKD) in the primary care setting. This trial will use family physicians in Ontario participating in the Electronic.

Conditions

Interventions

BEHAVIORAL

CKD feedback and tools

people in the intervention arm will receive feedback on ckd quality indicators and tools to help in the detection and management of ckd

Sponsors & Collaborators

  • Ontario Renal Network

    collaborator UNKNOWN

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Karen Tu, MD, MSc · ICES/Sunnybrook

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-04-30
Completion
2017-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02274298 on ClinicalTrials.gov